Salt storage
Showing 1 - 25 of 1,670
Non-muscle Invasive Bladder Cancer (NMIBC) Trial in Rozzano (Hyaluronic Acid (HA) sodium salt and Hydeal-D)
Terminated
- Non-muscle Invasive Bladder Cancer (NMIBC)
- Hyaluronic Acid (HA) sodium salt and Hydeal-D
-
Rozzano, Mi, ItalyHumanitas Research Hospital
Sep 29, 2023
Glycogen Storage Disease Type IA Trial in Worldwide (genetic, other, drug)
Recruiting
- Glycogen Storage Disease Type IA
- DTX401
- +3 more
-
Orange, California
- +16 more
Jan 13, 2023
Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Glycogenesis 2 Acid Maltase Deficiency Trial in Israel, United States
Terminated
- Pompe Disease
- +2 more
- Myozyme® (alglucosidase alfa)
-
Louisville, Kentucky
- +4 more
Mar 24, 2022
Pompe Disease, Glycogen Storage Disease Type II (GSD II) Trial in Worldwide (alglucosidase alfa)
Completed
- Pompe Disease
- Glycogen Storage Disease Type II (GSD II)
- alglucosidase alfa
-
Valhalla, New York
- +11 more
Mar 15, 2022
Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2 Trial in Worldwide (SPK-3006)
Active, not recruiting
- Pompe Disease
- +6 more
- SPK-3006
-
Phoenix, Arizona
- +28 more
Jul 22, 2022
SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
-
Anaheim, California
- +20 more
Nov 30, 2022
Obesity, Cardiovascular Risk Factor, Salt; Excess Trial in Nashville (Low-salt diet, High-salt diet)
Recruiting
- Obesity
- +2 more
- Low-salt diet
- High-salt diet
-
Nashville, TennesseeVanderbilt University Medical Center
Feb 2, 2022
Glycogen Storage Disease Type II;Pompe's Disease Trial in Worldwide (Avalglucosidase alfa (GZ402666), Alglucosidase alfa
Active, not recruiting
- Glycogen Storage Disease Type II;Pompe's Disease
- Avalglucosidase alfa (GZ402666)
- Alglucosidase alfa (GZ419829)
-
Phoenix, Arizona
- +68 more
May 3, 2022
Pompe Disease Trial in Worldwide (alglucosidase alfa)
Completed
- Pompe Disease
- alglucosidase alfa
-
Phoenix, Arizona
- +17 more
Jul 12, 2021
Hypertension Trial in Cambridge, London (Amlodipine, Chlortalidone)
Not yet recruiting
- Hypertension
-
Cambridge, United Kingdom
- +1 more
Jul 27, 2023
Sodium Storage in Singaporeans
Recruiting
- Healthy
- Hypertension
-
Singapore, Singapore
- +1 more
Aug 18, 2021
Genetic Collection Protocol
Recruiting
- Liver Diseases
-
Los Angeles, California
- +12 more
Jul 11, 2022
Injectable Contraception Cohort Study in Punjab, Pakistan
Not yet recruiting
- Contraceptive Usage
- Contraceptive usage
- (no location specified)
Mar 7, 2023
High Blood Pressure, Salt; Excess, Inflammation Trial in Nashville (Furosemide 40 mg)
Recruiting
- High Blood Pressure
- +2 more
- Furosemide 40 mg
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 27, 2021
Hypertension Trial in San Diego (High dietary sodium intake, Low dietary sodium intake)
Recruiting
- Hypertension
- High dietary sodium intake
- Low dietary sodium intake
-
San Diego, CaliforniaUniversity of California, San Diego
Dec 3, 2021
Water and Electrolytes Content in HYpertension (WHYSKI) in SKIn
Recruiting
- Hyperaldosteronism
- +7 more
- Skin Biopsy
- Video-laparoscopic adrenalectomy
-
Padova, ItalyAzienda Ospedale Università di Padova
Oct 23, 2023
Heart Failure With Reduced Ejection Fraction, Congestion Trial in New York (Ertugliflozin, Placebo)
Not yet recruiting
- Heart Failure With Reduced Ejection Fraction
- Congestion
- Ertugliflozin
- Placebo
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Nov 29, 2021
Salt-Sensitivity of Blood Pressure Trial (Furosemide (Diuretic), Hypertonic Saline Infusion)
Not yet recruiting
- Salt-Sensitivity of Blood Pressure
- Furosemide (Diuretic)
- Hypertonic Saline Infusion
- (no location specified)
Oct 17, 2023
Iron Deficiency Trial in New York (Iron-dextran, Saline, Blood Donation)
Active, not recruiting
- Iron Deficiency
- Iron-dextran
- +3 more
-
New York, New YorkColumbia University Medical Center
Feb 14, 2022
Peripheral Artery Disease (D058729), Oxidative Stress (D018384), Inflammation (D007249) Trial in Salt Lake City (PB125, Placebo,
Not yet recruiting
- Peripheral Artery Disease (D058729)
- +2 more
- PB125
- +2 more
-
Salt Lake City, Utah
- +1 more
Dec 8, 2022
Neural Tube Defects, Folic Acid Deficiency, Fortification Trial in Birmingham (Salt with folic acid and iodine)
Active, not recruiting
- Neural Tube Defects
- +2 more
- Salt with folic acid and iodine
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jul 6, 2023
Blood Pressure Trial (Reduced-sodium potassium-enriched salt)
Not yet recruiting
- Blood Pressure
- Reduced-sodium potassium-enriched salt
- (no location specified)
Jun 12, 2023
Nutrition, Healthy, Appetitive Behavior, Food Preferences Trial in Istanbul (Psyllium)
Completed
- Nutrition, Healthy
- +4 more
- Psyllium
-
Istanbul, Turkeyİstanbul Okan University
Apr 11, 2023
Postural Orthostatic Tachycardia Syndrome Trial (Sodium Chloride Capsules, Microcystalline Cellulose Capsules)
Not yet recruiting
- Postural Orthostatic Tachycardia Syndrome
- Sodium Chloride Capsules
- Microcystalline Cellulose Capsules
- (no location specified)
Jun 28, 2023
Blood Pressure Trial (Main study intervention-Salt substitute, Main study control-Usual salt, Ancillary study intervention-Meal
Not yet recruiting
- Blood Pressure
- Main study intervention-Salt substitute
- +3 more
- (no location specified)
Oct 19, 2023